Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.1055/s-0040-1705274
Submitted: 02-06-2022
Published: 02-06-2022

Efeitos dos ácidos graxos Ômega-3 no tratamento do transtorno depressivo maior: uma revisão

Médica, pós-graduanda em Nutrologia pela Associação Brasileira de Nutrologia (ABRAN), São Paulo, SP, Brasil
omega-3 diet depression

Abstract

The increased prevalence of depression in western countries has been accompanied by parallel increase of cardiovascular diseases and changes in eating habits, with an imbalance of consumption of omega-6 and omega-3 fatty acids. Recently, new therapeutic indications have been proposed for omega-3, such as the treatment of certain forms of mental illness, including depressive disorders. The objective of this study was to evaluate the current knowledge about the biological mechanisms of action of omega-3 in the prevention or treatment of major depressive disorder. The method adopted for the preparation of this review was based on a literature review of articles published in the international scientific research database sites such as Pubmed. The results presented in this review showed that there is an inverse association between the intake of omega-3 and prevalence of depression. Studies show that omega-3 acts as anti-inflammatory and improves the serotonergic and dopaminergic neurotransmission. However, there is significant need for further long-term studies to clarify the therapeutic dose and efficacy of omega-3 as monotherapy or adjunct for the treatment of major depressive disorder.

Metrics

Metrics Loading ...

References

  1. Sobocki P, Jönsson B, Angst J, Rehnberg C. Custo de depressão na Europa. Jornal de Política de Saúde Mental e Economia. 2006; 9 (2):. 87-98 [PubMed]
  2. Tiihonen J, J Lonnqvist, Wahlbeck K, et al. Sem saúde mental sem saúde física. The Lancet. 2011; 377(9766): p. 611. [PubMed]
  3. Stapelberg NJ, Neumann DL, Shum DHK, McConnell H, Hamilton-Craig I. Um mapa topográfico da rede causal de mecanismos subjacentes à relação entre transtorno depressivo maior e doença cardíaca coronária. Austrália e Nova Zelândia Journal of Psychiatry. 2011; 45 (5):. 351-369 [PubMed]
  4. Simopoulos AP. Resumo da conferência internacional sobre a variação genética e nutrição. World Review de Nutrição e Dietética. 1990; 63:. 1-13 [PubMed]
  5. Simopoulos AP, Ordovas J. Nutrigenética e Nutrigenômica. Vol. 93. Washington, DC, EUA: Karger;2004.
  6. Simopoulos AP. Aspectos evolutivos da dieta, a proporção de ômega-6/ômega-3 e variação genética: Implicações nutricionais para doenças crônicas. Biomedicina e Farmacoterapia. 2006; 60 (9): 502-507. [PubMed]
  7. Sinclair AJ, Begg D, M Mathai, Weisinger RS. Ácidos graxos ômega 3 e o cérebro: Revisão de estudos em depressão. Asia Pacific Journal of Clinical Nutrition. 2007; 16 (suplemento 1): 391-397 [PubMed]
  8. Brasil. Ministério da Saúde [homepage on the Internet].Pesquisa Nacional de Saúde: 57,4 milhões de brasileiros têm pelo menos uma doença crônica [cited 2014 Dez 10]. Available from: http://portalsaude.saude.gov.br/index.php/cidadao/principal/agencia-saude/15974-57-4-milhoes-de-brasileiros-tem-pelo-menos-uma-doenca-cronica
  9. Rost K, Zhang M, Fortney J, Smith J, Coyne J, Smith GR Jr. Persistently poor outcomes of undetected major depression in primary care. Gen Hosp Psychiatry. 1998;20(1):12-20.
  10. Ronalds C, Creed F, Stone K, Webb S, Tomenson B. Outcome of anxiety and depressive disorders in primary care. Br J Psychiatr. 1997;171:427-33.
  11. McQuaid JR, Stein MB, Laffaye C, McCahill ME. Depression in a primary care clinic: the prevalence and impact of an unrecognized disorder. J Affect Disord. 1999;55(1):1-10.
  12. Docherty JP. Barriers to the diagnosis of depression in primary care. J Clin Psychiatry. 1997;58 Suppl 1:5-10.
  13. American Psychiatric Association. (APA). Diagnostic and statistical manual of mental disorders (5th ed. 2013). Arlington, VA: American Psychiatric Publishing.
  14. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (4th ed.). (Página na Internet). Disponível em: http://www.psych.org/. Acesso em março de 2012.
  15. Halverson JL, Bienenfeld D. Depression. Medscape, 2011. Disponível em: http://emedicine.medscape.com/article/286759-overview#showall.
  16. Shapira B, Newman M, Lerer B. Serotonergic mechanisms in depression: clinical insights and biological correlates. Isr J Med Sci. 1994 Feb;30(2):162-7.
  17. Krishnan R. Epidemiology, pathogenesis, and neurobiology of depression. In: UpToDate, Basow, DS (Ed), UpTo-Date, Waltham, MA, 2012.
  18. Duval F, Lebowitz BD, Macher JP. Treatments in depression. Dialogues Clin Neurosci. 2006;8(2):191-206.
  19. Maes M, Yirmyia R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease. 2009 Mar;24(1):27-53. [PubMed]
  20. Wannmacher L. Depressão maior: da descoberta à solução? Uso racional de medicamentos: temas selecionados. Vol.1 No 5. Ano 2004.
  21. BRATS. Boletim Brasileiro de Avaliação de Tecnologias em Saúde. Antidepressivos no Transtorno Depressivo Maior em Adultos. ISSN 1983-7003; Ano VI nº 18; Março 2012.
  22. Massart R, R Mongeau, Lanfumey L. Além da hipótese monoaminérgico: Neuroplasticidade e alterações epigenéticas em um modelo de camundongo transgênico da depressão. Philosophical Transactions, da Royal Society de Londres. Série B: Ciências Biológicas. 2012; 367 (1601):. 2485-2494[PMC artigo livre] [PubMed]
  23. Chalon S. Ácidos graxos ômega-3 e neurotransmissão monoamina. Prostaglandins Leukot Essent Ácidos Graxos. 2006; 75 (4-5): 259-69 [PubMed]
  24. Nettleton JA. Ácidos graxos ômega-3 e Saúde. New York: Springer (anteriormente Chapman & Hall);1995.
  25. James MJ, Gibson RA, Cleland LG. Ácidos graxos poliinsaturados dietéticos e produção de mediadores inflamatórios. Am J Clin Nutr. 2000; 71:. 343S-348S [PubMed]
  26. Koski RR. Ésteres de ácido ômega-3-etil para hipertrigliceridemia grave. P & T. 2008; 33: 271-281. 303.
  27. Surette ME. A ciência por trás dos ácidos graxos ômega-3 na dieta. Pode Med Assoc J. 2008; 178:. 177-180[PMC artigo livre] [PubMed]
  28. Kris-Etherton PM, Harris WS, Appel LJ. Os ácidos graxos ômega-3 e doença cardiovascular: Novas recomendações da American Heart Association. Arterioscler Thromb Vasc Biol. 2003; 23:151-152. [PubMed]
  29. Kotwal S, Jun M, D Sullivan, Perkovic V, Neal B (2012). Ácidos graxos ômega-3 e desfechos cardiovasculares: revisão sistemática e meta-análise. Circ Cardiovasc Qua Outcomes 5: 808-818 [PubMed]
  30. Grosso L, Galvano F, Marventano S, Malaguarnera H, C Bucolo, et al. (2014). Ácidos graxos ômega-3 e Depressão: A evidência científica e mecanismos biológicos. Oxid Med Longev celular 2014: 313570. [PMC artigo livre] [PubMed]
  31. Machado-Vieira R, Mallinger AG (2012). A função anormal da monoamina oxidase-A no transtorno depressivo maior, comorbidade e doença cardiovascular: implicações fisiopatológicas e terapêuticas (comentário). Mol Med Rep 6: 915-922 [PubMed]
  32. Severus WE, Littman AB, Stoll AL (2001). Ácidos graxos ômega-3, homocisteína, e o risco aumentado de mortalidade cardiovascular em transtorno depressivo maior. Harv Rev Psiquiatria 9: 280-293 [PubMed]
  33. Bourre JM (2004). Papéis de ácidos graxos insaturados (especialmente ômega-3) no cérebro em várias idades e durante o envelhecimento. Envelhecimento J Nutr Saúde 8: 163-174 [PubMed]
  34. Hennebelle M, Balasse L, Latour A, et al. Influence of omega-3 fatty acid status on the way rats adapt to chronic restraint stress. PLoS ONE. 2012;7(7)e42142 [PMC free article] [PubMed]
  35. Simopoulos AP.A importância da proporção de ômega-6 / ômega-3 ácidos graxos essenciais. Biomedicina e Farmacoterapia. 2002; 56: 365-379. [PubMed]
  36. Hibbeln JR, Nieminen LR. Aumento das taxas de homicídio e de consumo de ácido linoleico entre os cinco países ocidentais, 1961-2000. Lipídios. 2004; 39: 1207-1213. [PubMed]
  37. Chalon S. O papel dos ácidos graxos no tratamento de ADHD. Neuropharmacology. 2009; 57:.636-639 [PubMed]
  38. McNamara RK, Carlson SE. Papel de ômega-3 ácidos graxos no desenvolvimento e função do cérebro: implicações potenciais para a patogênese e prevenção de psicopatologia. Prostaglandinas, leucotrienos e ácidos graxos essenciais. 2006; 75:. 329-349 [PubMed]
  39. Calder PC, Yaqoob P, Harvey DJ, Watts A, Newsholme EA. Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity.Biochemical Journal. 1994;300(2):509–518. [PMC free article] [PubMed]
  40. Lee CR, Hamm MW. Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane. Journal of Nutrition. 1989;119(4):539–546.[PubMed]
  41. Ahmad SN, Alma BS, Alam SQ. Dietary omega-3 fatty acids increase guanine nucleotide binding proteins and adenylate cyclase activity in rat salivary glands. The FASEB Journal. 1989;3, article A948
  42. Bowen RA, Clandinin MT. Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. Journal of Neurochemistry. 2002;83(4):764–774. [PubMed]
  43. Vaidyanathan VV, Rao KV, Sastry PS. Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. Neuroscience Letters. 1994;179(1-2):171–174. [PubMed]
  44. Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N., Jr. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late- onset alcoholics. Biological Psychiatry. 1998;44(4):235–242. [PubMed]
  45. Vines A, Delattre AM, Lima MMS, et al. The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism.Neuropharmacology. 2012;62(1):184–191. [PubMed]
  46. Delion S, Chalon S, Guilloteau D, Besnard J-C, Durand G. α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. Journal of Neurochemistry. 1996;66(4):1582–1591. [PubMed]
  47. McNamara RK, Able J, Liu Y, et al. Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. Journal of Psychiatric Research.2009;43(6):656–663. [PMC free article] [PubMed]
  48. Chalon S, Delion-Vancassel S, Belzung C, et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. Journal of Nutrition. 1998;128(12):2512–2519. [PubMed]
  49. Müller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Molecular Psychiatry. 2007;12(11):988–1000. [PubMed]
  50. Yan Q-S, Reith MEA, Jobe PC, Dailey JW. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Research. 1997;765(1):149–158. [PubMed]
  51. Martin P, Carlsson ML, Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. NeuroReport. 1998;9(13):2985–2988. [PubMed]
  52. Moreira JD, Knorr L, Ganzella M, et al. Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations. Neurochemistry International. 2010;56(6-7):753–759. [PubMed]
  53. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. The American Journal of Psychiatry. 2003;160(9):1554–1565. [PubMed]
  54. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2005;29(2):201–217. [PubMed]
  55. Ferraz AC, Delattre AM, Almendra RG, et al. Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol. Behavioural Brain Research. 2011;219(1):116–122. [PubMed]
  56. Song C, Li X, Leonard BE, Horrobin DF. Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats. Journal of Lipid Research. 2003;44(10):1984–1991. [PubMed]
  57. Krishnan V, Nestler EJ. Linking molecules to mood: new insight into the biology of depression. The American Journal of Psychiatry. 2010;167(11):1305–1320. [PMC free article] [PubMed]
  58. Wager-Smith K, Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neuroscience and Biobehavioral Reviews.2011;35(3):742–764. [PMC free article] [PubMed]
  59. Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Reviews Immunology. 2007;7(2):161–167. [PubMed]
  60. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. Journal of Clinical Investigation. 2001;108(1):15–23.[PMC free article] [PubMed]
  61. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition. 2006;83(supplement 6):S1505–S1519. [PubMed]
  62. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research.1999;85(3):275–291. [PubMed]
  63. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology. 2002;5(4):375–388. [PubMed]
  64. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, et al. Os ácidos graxos ômega-3: Bases das evidências para o tratamento e futuras pesquisas em psiquiatria. O Journal of Clinical Psychiatry 2006; 67: 1954-1967. [PubMed]
  65. Carmelli D, Swan GE, Robinette D, Fabsitz R. Influência genética sobre o tabagismo - um estudo de gêmeos do sexo masculino. New England Journal of Medicine. 1992; 327:. 829-833 [PubMed]

How to Cite

Santos, R. N. C. (2022). Efeitos dos ácidos graxos Ômega-3 no tratamento do transtorno depressivo maior: uma revisão. International Journal of Nutrology, 9(1), 144–152. https://doi.org/10.1055/s-0040-1705274